The variable presentation often leads to diagnostic delays, with many patients experiencing symptoms for years before diagnosis
Thanks to biochemical engineering, the glucagon-like peptide-1 (GLP-1) molecule has emerged as an essential element in the development of diverse agonists and multiagonists, based in the GLP-1 structure for obesity treatment
It activates one of the body's master regulators of metabolism, an enzyme called AMP kinase, triggering some of the same benefits that fasting and exercise provide to our cells
Consequently, TNF inhibitors, as primary biologics for managing autoimmune diseases, are naturally anticipated to be effective in treating AA
The hidden cost shows up when life gets busy: missed or inconsistent doses create uneven drug exposure, appetite rebounds, and an abrupt loss of progress that can be discouraging and harder to recover from